Thymosin Alpha-1

Thymosin Alpha-1 10mg

Thymosin Alpha‑1 (Tα1) – 28‑Amino Acid Thymic Peptide for Immunology Research

Thymosin Alpha‑1 (Tα1) is a synthetic 28‑amino acid peptide corresponding to a naturally occurring thymic fragment involved in the regulation of immune function. In preclinical and clinical research settings, Tα1 has been investigated for its ability to enhance T‑cell–mediated responses, activate natural killer and dendritic cells, and modulate cytokine signaling in models of infection, cancer, and immune dysregulation.

Key Research Features
• 28‑amino acid thymic peptide with defined sequence, suitable for mechanistic and translational immunology studies.
• Reported to enhance T‑cell differentiation and maturation and to support CD4+/CD8+ T‑cell responses in experimental systems.
• Shown to activate natural killer cells and dendritic cells and to influence antigen presentation via toll‑like receptor (TLR) pathways.
• Investigated for modulation of key cytokines and chemokines, including context‑dependent effects on IL‑6, TNF‑α, IL‑1β and IL‑10 in immune cells.
• Widely studied as an immunomodulatory adjunct in models of viral infection, malignancy, and other conditions characterized by immune imbalance.

Thymosin Alpha‑1 offered on this site is a laboratory research chemical intended strictly for in vitro, in vivo animal, and other controlled experimental use by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement and is not approved by the FDA for any therapeutic indication. This product is not intended for human or veterinary administration, diagnosis, treatment, cure, or prevention of any disease. Any mention of biological activities or published studies is provided solely to describe current scientific knowledge and must not be interpreted as medical advice or as a claim of efficacy or safety in humans. All purchasers are responsible for understanding and complying with applicable local regulations before ordering or using this material.